A detailed history of Everett Harris & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Everett Harris & CO holds 533,684 shares of ABBV stock, worth $88.9 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
533,684
Previous 537,076 0.63%
Holding current value
$88.9 Million
Previous $83.2 Million 16.76%
% of portfolio
1.3%
Previous 1.2%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $542,109 - $617,683
-3,392 Reduced 0.63%
533,684 $97.2 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $541,180 - $609,497
-3,933 Reduced 0.73%
537,076 $83.2 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $618,388 - $715,874
-4,629 Reduced 0.85%
541,009 $80.6 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $881,854 - $1.1 Million
-6,655 Reduced 1.2%
545,638 $73.5 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $152,563 - $175,699
-1,055 Reduced 0.19%
552,293 $88 Million
Q4 2022

Jan 20, 2023

SELL
$138.31 - $165.87 $278,003 - $333,398
-2,010 Reduced 0.36%
553,348 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $155,683 - $178,558
1,160 Added 0.21%
555,358 $74.5 Million
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $877,052 - $1.12 Million
-6,373 Reduced 1.14%
554,198 $84.9 Million
Q1 2022

Apr 22, 2022

BUY
$131.98 - $163.75 $207,076 - $256,923
1,569 Added 0.28%
560,571 $90.9 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $4.84 Million - $6.13 Million
45,083 Added 8.77%
559,002 $75.7 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $1.76 Million - $2 Million
16,551 Added 3.33%
513,919 $55.4 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $2.41 Million - $2.68 Million
22,903 Added 4.83%
497,368 $56 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $7.16 Million - $7.88 Million
69,949 Added 17.29%
474,465 $51.3 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $3.14 Million - $4.24 Million
39,004 Added 10.67%
404,516 $43.3 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $13,659 - $16,031
159 Added 0.04%
365,512 $32 Million
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $64,785 - $86,692
883 Added 0.24%
365,353 $35.9 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $643,194 - $975,161
9,972 Added 2.81%
364,470 $27.8 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $73,788 - $92,325
-1,023 Reduced 0.29%
354,498 $31.4 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $691,961 - $831,935
-10,987 Reduced 3.0%
355,521 $26.9 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $394,397 - $504,131
6,003 Added 1.67%
366,508 $26.7 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $155,051 - $182,487
-2,010 Reduced 0.55%
360,505 $29.1 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $1.25 Million - $1.54 Million
-16,001 Reduced 4.23%
362,515 $33.4 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $108,559 - $120,683
1,221 Added 0.32%
378,516 $35.8 Million
Q2 2018

Jul 27, 2018

BUY
$89.78 - $106.23 $11,491 - $13,597
128 Added 0.03%
377,295 $35 Million
Q1 2018

Apr 20, 2018

BUY
$92.01 - $123.21 $270,877 - $362,730
2,944 Added 0.79%
377,167 $35.7 Million
Q4 2017

Feb 01, 2018

SELL
$89.56 - $98.21 $55,079 - $60,399
-615 Reduced 0.16%
374,223 $36.2 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $26.2 Million - $33.4 Million
374,838
374,838 $33.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.